Gary L Tarbox, Age 852599 E Madison St, Seattle, WA 98112

Gary Tarbox Phones & Addresses

Mount Vernon, WA

2599 Madison St, Seattle, WA 98112 (206) 860-1221 (206) 860-1227

Bainbridge Island, WA

Mentions for Gary L Tarbox

Gary Tarbox resumes & CV records

Resumes

Gary Tarbox Photo 13

Gary Tarbox

Gary Tarbox Photo 14

Owner

Location:
Seattle, WA
Industry:
Non-Profit Organization Management
Work:
Northern Pacific Railway Historical Association
Vice President
Primarily Writing
Owner
Gary Tarbox Photo 15

Gary Tarbox

Publications & IP owners

Us Patents

Methods And Apparatus For Monitoring Cardiac Output

US Patent:
4796634, Jan 10, 1989
Filed:
Aug 9, 1985
Appl. No.:
6/763992
Inventors:
Lee L. Huntsman - Bainbridge Island WA
Richard S. Leard - Issaquah WA
Gary L. Tarbox - Bainbridge Island WA
Stephen R. Barnes - Seattle WA
Barry D. McLaren - Auburn WA
Assignee:
Lawrence Medical Systems, Inc. - Camarillo CA
International Classification:
A61B 1000
US Classification:
12866201
Abstract:
A method and apparatus for ascertaining the cardiac output of a human patient, said method comprising the steps of: measuring the systolic velocity of the blood flowing through the patient's descending aorta; determining the cross-sectional area of the patient's ascending aorta; and calculating the patient's cardiac output from said systolic velocity and said aortic area. The cardiac output can be converted: (1) to cardiac index by dividing it by the patient's body surface area, and (2) to systemic vascular resistance by dividing a value representing the patient's blood pressure by said cardiac output.

Carbon Dioxide Detection

US Patent:
5197464, Mar 30, 1993
Filed:
Dec 14, 1990
Appl. No.:
7/629055
Inventors:
Albert L. Babb - Seattle WA
Michael P. Hlastala - Seattle WA
Gary L. Tarbox - Seattle WA
International Classification:
A61M 1600
US Classification:
12820714
Abstract:
Methods and apparatus for ascertaining whether there is at least a threshold concentration of carbon dioxide in gases being monitored. Reversible hydration of the carbon dioxide to generate excess hydrogen ions and trigger a color change in a pH sensitive indicator is employed in represenative embodiments of the invention to provide a indication that the threshold concentration of carbon dioxide is present in the gases. The methods and apparatus may be used to distinguish between tracheal and esophageal intubation of human and other nammalian patients.

Carbon Dioxide Detection (Ii)

US Patent:
5291879, Mar 8, 1994
Filed:
Jul 23, 1992
Appl. No.:
7/918372
Inventors:
Albert L. Babb - Mercer Island WA
Michael P. Hlastala - Mercer Island WA
Gary L. Tarbox - Mercer Island WA
International Classification:
A61M 1600
US Classification:
12820026
Abstract:
Methods and apparatus for ascertaining whether there is at least a threshold concentration of carbon dioxide in gases being monitored. Reversible hydration of the carbon dioxide to generate excess hydrogen ions and trigger a color change in a pH sensitive indicator is employed in representative embodiments of the invention to provide an indication that the threshold concentration of carbon dioxide is present in the gases. The methods and apparatus may be used to distinguish between tracheal and esophageal intubation of human and other mammalian patients.

Method And System For Non-Invasive Ultrasound Doppler Cardiac Output Measurement

US Patent:
4509526, Apr 9, 1985
Filed:
Feb 8, 1983
Appl. No.:
6/464965
Inventors:
Stephen R. Barnes - Seattle WA
Gary L. Tarbox - Seattle WA
Lee L. Huntsman - Bainbridge Island WA
Barry D. McLaren - Auburn WA
Assignee:
Lawrence Medical Systems, Inc. - Redmond WA
International Classification:
A61B 1000
US Classification:
128663
Abstract:
A method and system for the noninvasive measurement of cardiac output of a mammalian patient on a real time, beat-by-beat basis as a combined function of the cross-sectional area of the ascending aorta and the systolic velocity of blood flow therethrough is comprised of the steps of and apparatus for pulsedly insonifying the ascending aorta of the patient with repetitive, intermittent ultrasonic energy propagating through the patient's cardiac window; receiving pulses of ultrasonic energy reflected from the anatomical structure within the first insonification zone, including energy reflected from the aortic walls and characteristic of the dimensional separation thereof; developing an aortic diameter signal indicative of dimensional separation; computing the cross-sectional area of the ascending aorta therefrom; then continuously insonifying the ascending aorta with uninterrupted ultrasonic energy; receiving a Doppler-shifted ultrasonic energy signal reflected from pulsatile blood flow through the ascending aorta, and characteristic of systolic velocity of blood flow; subjecting the systolic velocity signal to a frequency spectrum analysis at a predetermined signal sampling rate to yield a velocity component profile signal; integrating the velocity component profile signal over time; computing systolic volume as a combined function of cross-sectional area and the systolic velocity integral for each of n cardiac cycles; and, computing cardiac output as the time-averaged sum of systolic volumes for the n periods.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.